Search

everythinglearnresearchcommunity

for

Search:↓

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

People with alopecia areata often have thyroid autoimmunity.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Early intervention and patient education are crucial for managing alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

The patient quickly recovered from hair loss caused by DRESS syndrome using topical minoxidil.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A patient with a thick scalp and hair loss was correctly diagnosed with alopecia areata and a thick scalp fat layer, not lipedematous alopecia, and regrew hair after treatment.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

The patient accepted her hair loss and adapted by wearing a wig and tattooing her eyebrows.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Covid-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Two patients with stubborn hair loss grew hair after PDRN injections.

Asian patients show different trichoscopy features compared to Caucasians, like thicker hair and different alopecia signs.

Most patients with small patches of hair loss usually regrow hair.

Higher CRHR1 levels in AA patients lead to increased inflammation.